Bank of Montreal
TXMD icon

Bank of Montreal’s TherapeuticsMD TXMD Stock Holding History

Bank of Montreal’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-200
Closed -$13K – 4878
2021
Q1 		$13K Sell
200
-9,509
-98% -$744K ﹤0.01% 4244
2020
Q4 		$690K Buy
9,709
+590
+6% +$40.3K ﹤0.01% 2519
2020
Q3 		$730K Buy
9,119
+8,740
+2,306% +$697K ﹤0.01% 2133
2020
Q2 		$28K Buy
+379
New +$22.1K ﹤0.01% 3701
2020
Q1 		– Sell
-2,916
Closed -$353K – 4717
2019
Q4 		$353K Sell
2,916
-4,344
-60% -$625K ﹤0.01% 2855
2019
Q3 		$1.32M Buy
7,260
+4,293
+145% +$605K ﹤0.01% 1949
2019
Q2 		$385K Buy
2,967
+1,487
+100% +$267K ﹤0.01% 2575
2019
Q1 		$361K Sell
1,480
-61
-4% -$16.1K ﹤0.01% 2435
2018
Q4 		$294K Sell
1,541
-1,414
-48% -$345K ﹤0.01% 2406
2018
Q3 		$969K Sell
2,955
-109
-4% -$33.4K ﹤0.01% 2017
2018
Q2 		$955K Sell
3,064
-56
-2% -$17.1K ﹤0.01% 2025
2018
Q1 		$761K Buy
3,120
+1,640
+111% +$460K ﹤0.01% 2043
2017
Q4 		$447K Buy
1,480
+20
+1% +$5.57K ﹤0.01% 2335
2017
Q3 		$386K Sell
1,460
-10
-0.7% -$2.89K ﹤0.01% 2389
2017
Q2 		$388K Sell
1,470
-24
-2% -$6.01K ﹤0.01% 2375
2017
Q1 		$538K Hold
1,494
– – ﹤0.01% 2086
2016
Q4 		$444K Buy
1,494
+34
+2% +$10.5K ﹤0.01% 2167
2016
Q3 		$497K Hold
1,460
– – ﹤0.01% 2090
2016
Q2 		$621K Hold
1,460
– – ﹤0.01% 2031
2016
Q1 		$467K Sell
1,460
-982
-40% -$335K ﹤0.01% 2075
2015
Q4 		$1.27M Buy
2,442
+8
+0.3% +$2.95K ﹤0.01% 1619
2015
Q3 		$713K Hold
2,434
– – ﹤0.01% 1701
2015
Q2 		$957K Buy
+2,434
New +$859K ﹤0.01% 1682
2014
Q3 		– Sell
-45
Closed -$10K – 4402
2014
Q2 		$10K Buy
+45
New +$10K ﹤0.01% 3879

Other funds holding TXMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Bank of Montreal's TXMD Position: Q2 2021 in Review

Bank of Montreal sold out of TherapeuticsMD (TXMD) in Q2 2021, closing a stake of 200 shares — an estimated $13K sold.

Bank of Montreal first reported a position in TXMD in Q2 2014 and held it in 24 quarters. The position peaked at $1.32M in Q3 2019. 154 funds tracked by Wall St. Rank hold TXMD as of Q2 2021.

  • Bank of Montreal reported no remaining TherapeuticsMD position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 200 TherapeuticsMD shares in Q2 2021, an estimated $13K.
  • Bank of Montreal first reported a position in TherapeuticsMD in Q2 2014 and held it in 24 quarters.
  • Bank of Montreal's TherapeuticsMD position peaked at $1.32M in Q3 2019.
  • 154 funds tracked by Wall St. Rank held TherapeuticsMD as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.